Charles Morgan Kendrick Jr Elevance Health, Inc. (ELV) insider trading activity

Charles Morgan Kendrick Jr is EVP & President, Commercial of Elevance Health, Inc.. Currently has a direct ownership of 10,116 shares of ELV, which is worth approximately $4.19 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 3,504 shares (Common Stock) at a price of $396.3 per share, resulting in proceeds of $1,388,635. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.1K

33.51% 3M change

36.14% 12M change

Total Value Held $4.19 Million

Charles Morgan Kendrick Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Open market or private sale	$1,388,635 $396.3 p/Share	3,504 Reduced 25.73%	10,116 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$878,405 $395.5 p/Share	2,221 Reduced 23.86%	7,089 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	-	6,531 Added 32.41%	13,620 Common Stock
Nov 01 2024	SELL Payment of exercise price or tax liability	$350,252 $414.01 p/Share	846 Reduced 10.04%	7,577 Common Stock
Nov 01 2024	BUY Grant, award, or other acquisition	-	1,710 Added 15.55%	9,287 Common Stock
Oct 18 2024	SELL Open market or private sale	$3,205,182 $432.14 p/Share	7,417 Reduced 46.82%	8,423 Common Stock
Mar 08 2024	SELL Open market or private sale	$1,217,118 $500.46 p/Share	2,432 Reduced 13.31%	15,840 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$740,679 $499.11 p/Share	1,484 Reduced 9.73%	13,764 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	4,508 Added 19.79%	18,272 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$35,286 $446.66 p/Share	79 Reduced 0.52%	15,248 Common Stock
Mar 09 2023	SELL Open market or private sale	$1,069,577 $462.22 p/Share	2,314 Reduced 13.12%	15,327 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$508,157 $468.78 p/Share	1,084 Reduced 5.79%	17,641 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$137,425 $469.03 p/Share	293 Reduced 2.03%	14,157 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	4,568 Added 19.61%	18,725 Common Stock
Nov 01 2022	SELL Payment of exercise price or tax liability	$43,017 $544.53 p/Share	79 Reduced 0.54%	14,450 Common Stock
Jun 09 2022	SELL Open market or private sale	$3,097,936 $489.56 p/Share	6,328 Reduced 30.34%	14,529 Common Stock
Jun 09 2022	BUY Exercise of conversion of derivative security	$1,775,763 $280.62 p/Share	6,328 Added 23.28%	20,857 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$50,984 $463.49 p/Share	110 Reduced 0.75%	14,529 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$363,006 $451.5 p/Share	804 Reduced 7.01%	10,670 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	3,969 Added 21.33%	14,639 Common Stock
Nov 01 2021	BUY Grant, award, or other acquisition	-	525 Added 4.38%	11,474 Common Stock

CMK

Charles Morgan Kendrick Jr

EVP & President, Commercial

Indianapolis, IN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELV shares.

Notify only if

Value

Insider Trading

Get notified when an Elevance Health, Inc. insider buys or sells ELV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Elevance Health, Inc.

Track Activities on ELV

Account